Sort
16,300 grants matching “fatty liver disease”
Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease
$103,598Nezam Hassan Afdhal · Beth Israel Deaconess Medical Center · U01 · FY2010 · AT
Metabolic health phenotype, accelerated aging and obesity-related cancer risk and mortality
$103,583Prasoona Karra · Dartmouth College · K00 · FY2024 · CA
Daily Rhythms and Health: Obesity and Related Disorders
$103,543Julie S Pendergast · University Of Kentucky · K01 · FY2015 · DK
Sympathetic Control of Liver Metabolism in Exercise and Obesity
$103,385Stanislaw Marek Deja · Ut Southwestern Medical Center · K01 · FY2024 · DK
Sympathetic Control of Liver Metabolism in Exercise and Obesity
$103,385Stanislaw Marek Deja · Ut Southwestern Medical Center · K01 · FY2025 · DK
Sympathetic Control of Liver Metabolism in Exercise and Obesity
$103,385Stanislaw Marek Deja · Ut Southwestern Medical Center · K01 · FY2023 · DK
Mechanisms of glycine-based therapy for atherosclerosis
$103,355Oren Shalom Rom · University Of Michigan At Ann Arbor · K99 · FY2020 · HL
Mechanisms of glycine-based therapy for atherosclerosis
$103,355Oren Shalom Rom · University Of Michigan At Ann Arbor · K99 · FY2021 · HL
The Role of ChREBP in Fructose Induced Metabolic Disease
$103,350Mark A Herman · Duke University · R01 · FY2016 · DK
CELL MORHOLOGY CORE
$103,216Peter L Bell · University Of Pennsylvania · P01 · FY2012 · HL
Determining the Function of PNPLA3 Utilizing Metabolomics and Stable Isotope Labe
$103,204Matthew Alvin Mitsche · Ut Southwestern Medical Center · K01 · FY2016 · GM
Determining the Function of PNPLA3 Utilizing Metabolomics and Stable Isotope Labe
$103,204Matthew Alvin Mitsche · Ut Southwestern Medical Center · K01 · FY2014 · GM
Determining the Function of PNPLA3 Utilizing Metabolomics and Stable Isotope Labe
$103,204Matthew Alvin Mitsche · Ut Southwestern Medical Center · K01 · FY2013 · GM
Determining the Function of PNPLA3 Utilizing Metabolomics and Stable Isotope Labe
$103,204Matthew Alvin Mitsche · Ut Southwestern Medical Center · K01 · FY2015 · GM
Regulation of Islet Beta-Cell Function via Islet-Derived VGF Peptides
$103,161Samuel Brandon Stephens · Duke University · K01 · FY2015 · DK
Regulation of Islet Beta-Cell Function via Islet-Derived VGF Peptides
$103,161Samuel Brandon Stephens · Duke University · K01 · FY2013 · DK
Regulation of Islet Beta-Cell Function via Islet-Derived VGF Peptides
$103,161Samuel Brandon Stephens · Duke University · K01 · FY2014 · DK
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE
$103,154Arun J Sanyal · Virginia Commonwealth University · M01 · FY2008 · RR
Metabolic Core
$103,025Colleen Marie Croniger · Case Western Reserve University · U2C · FY2016 · DK
Role of Muscle Ketone Metabolism in Mediating the Metabolic Benefits of Weight Loss
$103,020Ashley Silberman Williams · Duke University · K01 · FY2020 · DK
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
$102,995David E Cohen · Brigham And Women'S Hospital · R01 · FY2016 · DK
MITOCHONDRIAL OXIDATIVE ENZYME EXPRESSION
$102,951Massachusetts General Hospital · K02 · FY2000 · DK
Exercise dose and nonalcoholic fatty liver disease
$102,882Erik P Kirk · Southern Illinois Univ At Edwardsville · K01 · FY2009 · DK
Adipose-Specific Phosphatidic Acid Acid Phosphatase Activity of Lipin 1 Regulates Systemic Insulin Sensitivity
$102,869Andrew Lutkewitte · University Of Kansas Medical Center · K01 · FY2024 · DK
Adipose-Specific Phosphatidic Acid Acid Phosphatase Activity of Lipin 1 Regulates Systemic Insulin Sensitivity
$102,869Andrew Lutkewitte · University Of Kansas Medical Center · K01 · FY2023 · DK